Commentary

The world's new trade routes are electronic, but the United States has failed to make the necessary investments in high-speed broadband, according to columnist James Carlini. In this edition of Carlini's Comments, he said America's reputation as a technology leader will be damaged if it...

The bloom is off the rose for biofuels, as higher food prices are linked to biofuel production, food riots have spread across developing nations, and as a United National official called use of food crops to produce ethanol a crime against humanity. In this edition...

As exciting as the stem cell science was at Promega Corp.'s third annual Stem Cell Symposium, there remain problems to resolve before stem cells are used in the clinic. In this edition of Biotech Takes, columnist Steve Clark took in updates from the likes of...

Angel investments and venture capital have done more than other investment classes to promote company formation, and it looks as though the slowing economy will not derail their momentum. In advance of an annual report on early-stage investment activity in Wisconsin, columnist Tom Still notes...

Clinging to regional economic rivalries misses the point of the global economy, according to columnist Tom Still. In this edition of Inside Wisconsin, Still writes that in the knowledge economy of the 21st Century, the real competition is global and so it makes sense for...

The lack of good-paying jobs for American citizens is reflected with the latest multi-billion dollar financial collapse, which affirms previous economic observations of columnist James Carlini. In this edition of Carlini's Comments, he notes that cheap labor is not cheap, and judging by the rate...

Whenever a software vendor tries to dictate the terms of a software license, the purchasing company should consider it a red flag, advises columnist and attorney Mark Foley. In this edition of Digital Lex, Foley says standard vendor agreements should be viewed as a starting...

Jim Maurer was one of AT&T's lobbyists on the controversial bill to create statewide franchises for telecommunications companies interested in providing video services, including television. As a lobbyist, it was his job to advocate in favor of a bill, now a law, that will provide...

Led by Big Pharma's thirst for new biotech products, WTN columnist Michael Rosen reports that biotech financing remains strong despite spotty economic conditions. In this edition of Yer Biotech Blues, Rosen uses information from Wisconsin native and biotech booster Steve Burrill to track some welcome...